Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Research and Clinical Diagnostic Tests and Controls
  4. Other Controls and Reagents
  5. Blood Bank Reagents
  6. 23287403

QuidelOrtho Anti-D Sera and Rh-hr Typing Reagents: QuidelOrtho Rh-hr Control
SDP

Catalog No. 23287403
Change view
Click to view available options
Quantity:
15 x 10 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
23-287403 15 x 10 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Contains sodium azide. Sodium azide may react with lead and copper plumbing to form highly explosive metal azide. On disposal, flush with a large volume of water to prevent azide buildup.
Catalog No. 23-287403 Supplier QuidelOrtho Supplier No. 715480
Only null left
Add to Cart
Add to Cart
This item is not returnable. View return policy
Contains sodium azide. Sodium azide may react with lead and copper plumbing to form highly explosive metal azide. On disposal, flush with a large volume of water to prevent azide buildup.

Description

The Rh-hr control reagent is designed to recognize spontaneous agglutination of red blood cells

  • The control is prepared from pools of human serum tested and found to be negative for blood group antibodies

Specifications

Type Rh-hr Control Reagent
For Use With (Application) To recognize spontaneous Agglutination of red Blood cells
Quantity 15 x 10 mL
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.